Multidisease Testing for HIV and TB Using the Genexpert Platform: A Feasibility Study in Rural Zimbabwe

Search the VL-EID Archive

Ndlovu Z, et al. 2018. PLoS ONE 13(3): e0193577. DOI: 10.1371/journal.pone.0193577.

This Medecins Sans Frontières study evaluated the operational feasibility of integrated HIV viral load (VL), early infant diagnosis (EID), and tuberculosis (MTB/RIF) testing in new GeneXpert platforms in Zimbabwe. Findings from this study supported that implementation of near point-of-care platforms for integrated multi-disease testing is feasible and will increase access to VL and EID testing to priority populations.